Avanti Polar Lipids, Inc.

What Avanti Polar Lipids, Inc. does

Avanti Polar Lipids, Inc., legally Avanti Polar Lipids, LLC and operating commercially as Avanti Research, manufactures high-purity phospholipids, sphingolipids, sterols, PEGylated lipids, and cationic lipids for scientific research and pharmaceutical applications. Founded in 1967 and headquartered in Alabaster, Alabama, the company has built an integrated capability set spanning catalog research-use-only (RUO) lipids, custom synthesis, lipidomics and analytical services, formulations development for liposomes, lipid nanoparticles (LNPs), emulsions, and adjuvants, and cGMP contract manufacturing of pharmaceutical-grade lipids for clinical and commercial supply. Its product range covers nucleic acid delivery (mRNA, siRNA, gene therapy), vaccine adjuvant systems, protein and peptide delivery, and small molecule delivery, with named products including DSPE-PEG(2000) Maleimide, Plasma Ceramide SPLASH, DOPE (18:1 PE), and DOTAP.

The company monetizes through a hybrid model: unit-priced catalog sales of RUO lipids via a direct e-commerce platform with quick reorder and account management features, paired with account-based, contract-style engagements for cGMP manufacturing, custom synthesis, and formulations development projects. Distribution combines self-serve online ordering for the research long tail with direct enterprise sales for pharmaceutical and diagnostic customers; the company explicitly markets itself as supporting customers from concept through commercialization. Avanti is wholly owned by UK-listed specialty chemicals conglomerate Croda International Plc (LSE: CRDA), and operates as the Avanti Research brand under Croda's Health Care portfolio, leveraging parent distribution and scale-up resources while maintaining a specialized focus on lipid chemistry.

Its customer base is concentrated in pharmaceutical companies developing lipid-based drug formulations and nucleic acid therapeutics, diagnostic manufacturers requiring high-quality lipid reagents, and academic and government research institutions. The firm holds NSF ISR certification and markets cGMP-compliant supply for clinical and commercial use. Recent strategic emphasis has been on nucleic acid delivery applications, exemplified by a 2026 collaboration with NovoArc on archaeal tetraether lipid LNPs, and on operational integration with Croda via a June 2026 SAP migration affecting RUO product codes.

Name

Avanti Polar Lipids, Inc.

Legal name

Avanti Polar Lipids, LLC

Website

https://avantilipids.com

Company type

Private

Founded year

1967

Operating status

Operating

Headcount range

101–250 employees

Short description

Avanti Polar Lipids, operating as Avanti Research, is a Croda-owned manufacturer of high-purity phospholipids, sphingolipids, and sterols serving pharmaceutical companies, diagnostic manufacturers, and academic researchers with catalog lipids, cGMP manufacturing, custom synthesis, and lipid-based formulation development.

Ownership category

akta.pro rank

Product category

Specialty Lipid Manufacturing

NAICS

Starch and Vegetable Fats and Oils Manufacturing (31122)

SIC

Medicinal Chemicals & Botanical Products (2833), Fats & Oils (2070)

akta.pro primary industry

Omega-3 & Specialty Lipids (Fish/Algal Oils, EPA/DHA, MCTs, CLA, Phospholipids) (AFAJAKAC)

akta.pro secondary industry

Metabolomics & Lipidomics Services (HLAGANAG)

Keywords

• Phospholipid manufacturing
• Lipid nanoparticle formulations
• CGMP lipid production
• Research lipid supply
• Lipid-based drug delivery

Headquarters

HQ city

Alabaster

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Research Products: Sale of high-purity lipid research products including phospholipids, fatty acids, PEGylated lipids, and specialty lipids through e-commerce platform
2. cGMP Manufacturing Services: Contract manufacturing of pharmaceutical-grade lipids under cGMP conditions for clinical trials and commercial supply
3. Analytical Services: Lipid analysis and testing services for quality control and research support
4. Formulations Development: Custom formulation development services for lipid-based drug delivery systems

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Avanti Polar Lipids (operating as Avanti Research) manufactures high-purity phospholipids, sphingolipids, sterols, PEGylated lipids, and cationic lipids for scientific research and pharmaceutical applications. The company sells research-grade lipid products via its e-commerce platform and provides cGMP contract manufacturing, custom synthesis, lipid-based formulation development (LNPs, liposomes, emulsions), and lipidomics analytical services for pharmaceutical, diagnostic, and research customers.

Product overview

Avanti Research offers high-purity lipids for scientific research along with cGMP manufacturing, analytical services, and lipidomics solutions. The product portfolio includes research products (lipids, phospholipids, PEGylated lipids), custom synthesis services, formulations development (adjuvant systems, nucleic acid delivery, protein delivery, small molecule delivery), cGMP manufacturing for pharmaceutical applications, and lipidomics services. The company operates as a Croda brand, providing products and services from research through commercialization, with offerings including specific lipid products like DSPE-PEG(2000) Maleimide, Plasma Ceramide SPLASH, DOPE, and laboratory equipment such as extruder sets.

Differentiator

Problem solved

Functional benefit

Products and services

• cGMP Manufacturing Contract manufacturing services for pharmaceutical-grade lipids under cGMP conditions, supporting clinical and commercial supply for pharmaceutical customers.
• Formulations Development Development services for lipid-based drug formulations including adjuvants, nucleic acid delivery systems (LNPs for mRNA/siRNA), protein/peptide delivery, and small molecule delivery.
• Lipidomics & Custom Lipidomics Mixtures Analytical lipidomics services and custom lipidomics mixtures used for lipid profiling, biomarker research, and diagnostic assay development.
• Custom Synthesis Custom synthesis services producing specialized lipids and lipid derivatives to meet unique research and pharmaceutical development requirements.
• DSPE-PEG(2000) Maleimide PEGylated lipid used in drug delivery and liposome formulation research.
• Plasma Ceramide SPLASH™ Plasma ceramide mixture used as a quantitative lipidomics standard for research and analytical applications.
• DOPE (18:1 PE) Dioleoylphosphatidylethanolamine (DOPE), a neutral phospholipid used in liposome and lipid nanoparticle formulations for drug delivery research.
• Extruder Set With Holder/Heating Block Laboratory extruder equipment used to prepare liposomes and lipid nanoparticles and to control particle size during formulation.
• Adjuvant Systems Lipid-based adjuvant systems designed for vaccine and immunotherapy applications.
• Nucleic Acid Delivery Lipid nanoparticle formulations and supporting lipids for mRNA, siRNA, and gene therapy delivery applications.
• Protein Delivery Lipid-based systems for the delivery of protein and peptide therapeutics.
• Small Molecule Delivery Lipid-based formulations for oral and injectable delivery of small molecule drugs.

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• NovoArccoreStrategic or Co-development PartnerAvanti Research and NovoArc are collaborating on lipid nanoparticle and liposome design using archaeal tetraether lipids. This partnership advances next-generation delivery systems for nucleic acid therapeutics and vaccines, combining Avanti's lipid expertise with NovoArc's platform technology.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Lipoid GmbH: German manufacturer of high-purity phospholipids and specialty lipids for pharmaceutical, cosmetic, and food applications. Most direct comparable to Avanti in phospholipid chemistry and pharma-grade lipid manufacturing, and co-listed among leading industry manufacturers.
• NOF Corporation: Japanese specialty chemical company with a major phospholipid and PEG-lipid franchise serving drug delivery and LNP formulation markets. Highly comparable to Avanti in serving nucleic acid delivery and pharmaceutical excipient customers.
• CordenPharma: Global CDMO offering lipid-based drug formulation and manufacturing services, including LNPs for mRNA therapeutics. Directly comparable to Avanti's cGMP manufacturing and formulation development service lines.
• Cayman Chemical: US-based supplier of high-purity research biochemicals including lipids, lipid mediators, and lipidomics standards. Directly comparable to Avanti's research products catalog and custom synthesis offerings.
• ABITEC Corporation: US specialty lipid manufacturer producing phospholipids, structured lipids, and functional lipid ingredients for pharmaceutical, nutritional, and industrial applications. Closely comparable to Avanti in lipid chemistry specialization.
• Echelon Biosciences: Specialty supplier of lipid research reagents, lipid nanoparticles, and custom lipid synthesis services for academic and industrial researchers. Comparable niche overlap with Avanti's research products and custom synthesis business.

Broad incumbents

• Evonik Industries: Global specialty chemicals company with significant pharmaceutical excipients and lipid system offerings (including RESOMER bioresorbable polymers and lipid-based delivery solutions). Comparable as a broader incumbent serving pharmaceutical delivery and formulation customers.
• Merck KGaA (Life Science/Sigma-Aldrich): Major life science tools and reagents supplier offering an extensive catalog of lipids, lipid conjugates, and LNP components under the Sigma-Aldrich and Supelco brands. Comparable as a broad incumbent serving research and pharmaceutical lipid demand.
• Croda International Plc (Parent): UK-listed specialty chemicals conglomerate that owns Avanti Polar Lipids and operates adjacent life sciences, pharmaceutical, and personal care ingredient franchises. Provides the strategic, distribution, and capital context for Avanti's positioning.

Emerging players

• Bio-Techne: Life sciences tools company offering lipid-based reagents, exosomes, and nucleic acid delivery reagents through its Tocris, R&D Systems, and ProteinSimple brands. Emerging competitor in lipid-enabled delivery reagents with broader portfolio reach.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/avantilipids
• YouTubeyoutube.com/channel/UC7mshvXD3tevqUcTUFsZ_Aw
• LinkedInlinkedin.com/company/avanti-polar-lipids-inc-
• Facebookfacebook.com/avantilipids

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Avanti Polar Lipids, Inc.